Ann: June 2024 Quarterly Activities Report and Appendix 4C, page-9

You forget that Europe has twice as many diabetics as the states, if they can break into that market and sell a similar number of tests there, as they hopefully will do in America, their income should surely be well over a hundred million Aussie per year. Diabetes is a global problem that is only going to get worse, so this test imo will need to be administered far more commonly than investors realize.

I am very surprised there is not more thirst from investors on this one because once this test is up and running, Proteomics will be a very profitable company, one which should be able to pay a decent dividend fairly quickly. Not to mention they have other tests, which will also be positive for their bottom line going forward. That's why I know, with the holdings I have, I'll be looking at a very comfortable retirement within the next few years. Patience will be rewarded with this one.